These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 30825248)

  • 81. Use of a standardized cell culture assay to assess activities of nucleoside analogs against hepatitis B virus replication.
    Korba BE; Gerin JL
    Antiviral Res; 1992 Jul; 19(1):55-70. PubMed ID: 1444322
    [TBL] [Abstract][Full Text] [Related]  

  • 82. A New Role for Capsid Assembly Modulators To Target Mature Hepatitis B Virus Capsids and Prevent Virus Infection.
    Ko C; Bester R; Zhou X; Xu Z; Blossey C; Sacherl J; Vondran FWR; Gao L; Protzer U
    Antimicrob Agents Chemother; 2019 Dec; 64(1):. PubMed ID: 31658963
    [TBL] [Abstract][Full Text] [Related]  

  • 83. Inhibition of hepatitis B virus replication by N-hydroxyisoquinolinediones and related polyoxygenated heterocycles.
    Edwards TC; Lomonosova E; Patel JA; Li Q; Villa JA; Gupta AK; Morrison LA; Bailly F; Cotelle P; Giannakopoulou E; Zoidis G; Tavis JE
    Antiviral Res; 2017 Jul; 143():205-217. PubMed ID: 28450058
    [TBL] [Abstract][Full Text] [Related]  

  • 84. Isolation, synthesis and anti-hepatitis B virus evaluation of p-hydroxyacetophenone derivatives from Artemisia capillaris.
    Zhao Y; Geng CA; Chen H; Ma YB; Huang XY; Cao TW; He K; Wang H; Zhang XM; Chen JJ
    Bioorg Med Chem Lett; 2015 Apr; 25(7):1509-14. PubMed ID: 25737008
    [TBL] [Abstract][Full Text] [Related]  

  • 85. Design, synthesis, and antihepatitis B virus activities of novel 2-pyridone derivatives.
    Lv Z; Sheng C; Wang T; Zhang Y; Liu J; Feng J; Sun H; Zhong H; Niu C; Li K
    J Med Chem; 2010 Jan; 53(2):660-8. PubMed ID: 20000776
    [TBL] [Abstract][Full Text] [Related]  

  • 86. Novel non-heteroarylpyrimidine (HAP) capsid assembly modifiers have a different mode of action from HAPs in vitro.
    Corcuera A; Stolle K; Hillmer S; Seitz S; Lee JY; Bartenschlager R; Birkmann A; Urban A
    Antiviral Res; 2018 Oct; 158():135-142. PubMed ID: 30031759
    [TBL] [Abstract][Full Text] [Related]  

  • 87. Synthesis and biological evaluation of 2',3'-dideoxy-L-pyrimidine nucleosides as potential antiviral agents against human immunodeficiency virus (HIV) and hepatitis B virus (HBV).
    Lin TS; Luo MZ; Liu MC; Pai SB; Dutschman GE; Cheng YC
    J Med Chem; 1994 Mar; 37(6):798-803. PubMed ID: 8145230
    [TBL] [Abstract][Full Text] [Related]  

  • 88. Design, synthesis, and bioassay of 4-thiazolinone derivatives as influenza neuraminidase inhibitors.
    Xiao M; Xu L; Lin D; Lian W; Cui M; Zhang M; Yan X; Li S; Zhao J; Ye J; Liu A; Hu A
    Eur J Med Chem; 2021 Mar; 213():113161. PubMed ID: 33540229
    [TBL] [Abstract][Full Text] [Related]  

  • 89. Preclinical Characterization of NVR 3-778, a First-in-Class Capsid Assembly Modulator against Hepatitis B Virus.
    Lam AM; Espiritu C; Vogel R; Ren S; Lau V; Kelly M; Kuduk SD; Hartman GD; Flores OA; Klumpp K
    Antimicrob Agents Chemother; 2019 Jan; 63(1):. PubMed ID: 30373799
    [TBL] [Abstract][Full Text] [Related]  

  • 90. Novel Pyrimidine Toll-like Receptor 7 and 8 Dual Agonists to Treat Hepatitis B Virus.
    McGowan D; Herschke F; Pauwels F; Stoops B; Last S; Pieters S; Scholliers A; Thoné T; Van Schoubroeck B; De Pooter D; Mostmans W; Khamlichi MD; Embrechts W; Dhuyvetter D; Smyej I; Arnoult E; Demin S; Borghys H; Fanning G; Vlach J; Raboisson P
    J Med Chem; 2016 Sep; 59(17):7936-49. PubMed ID: 27513093
    [TBL] [Abstract][Full Text] [Related]  

  • 91. Antiviral Research--16th International Congress: HBV and HCV. 27 April-1 May 2003, Savannah, GA, USA.
    Smee D
    IDrugs; 2003 Jun; 6(6):518-21. PubMed ID: 12861975
    [No Abstract]   [Full Text] [Related]  

  • 92. Synergistic Interactions between Hepatitis B Virus RNase H Antagonists and Other Inhibitors.
    Lomonosova E; Zlotnick A; Tavis JE
    Antimicrob Agents Chemother; 2017 Mar; 61(3):. PubMed ID: 27956427
    [TBL] [Abstract][Full Text] [Related]  

  • 93. Design, synthesis, and biological evaluation of new 2'-deoxy-2'-fluoro-4'-triazole cytidine nucleosides as potent antiviral agents.
    Wu J; Yu W; Fu L; He W; Wang Y; Chai B; Song C; Chang J
    Eur J Med Chem; 2013 May; 63():739-45. PubMed ID: 23570720
    [TBL] [Abstract][Full Text] [Related]  

  • 94. Discovery and Pre-Clinical Characterization of Third-Generation 4-H Heteroaryldihydropyrimidine (HAP) Analogues as Hepatitis B Virus (HBV) Capsid Inhibitors.
    Qiu Z; Lin X; Zhang W; Zhou M; Guo L; Kocer B; Wu G; Zhang Z; Liu H; Shi H; Kou B; Hu T; Hu Y; Huang M; Yan SF; Xu Z; Zhou Z; Qin N; Wang YF; Ren S; Qiu H; Zhang Y; Zhang Y; Wu X; Sun K; Zhong S; Xie J; Ottaviani G; Zhou Y; Zhu L; Tian X; Shi L; Shen F; Mao Y; Zhou X; Gao L; Young JAT; Wu JZ; Yang G; Mayweg AV; Shen HC; Tang G; Zhu W
    J Med Chem; 2017 Apr; 60(8):3352-3371. PubMed ID: 28339215
    [TBL] [Abstract][Full Text] [Related]  

  • 95. Design, Synthesis, and Biological Evaluation of Novel Thioureidobenzamide (TBA) Derivatives as HBV Capsid Assembly Modulators.
    Wang M; Zhang J; Dou Y; Liang M; Xie Y; Xue P; Liu L; Li C; Wang Y; Tao F; Zhang X; Hu H; Feng K; Zhang L; Wu Z; Chen Y; Zhan P; Jia H
    J Med Chem; 2023 Oct; 66(20):13968-13990. PubMed ID: 37839070
    [TBL] [Abstract][Full Text] [Related]  

  • 96. Design and synthesis of novel quinazolinone derivatives as anti-HBV agents with TLR8 agonist effect.
    Qiu J; Zhou Q; Zou Y; Li S; Yang L; Chen W; Gao J; Gu X
    Eur J Med Chem; 2022 Mar; 231():114159. PubMed ID: 35123297
    [TBL] [Abstract][Full Text] [Related]  

  • 97. Allosteric inhibitors of Coxsackie virus A24 RNA polymerase.
    Schein CH; Rowold D; Choi KH
    Bioorg Med Chem; 2016 Feb; 24(4):570-7. PubMed ID: 26762834
    [TBL] [Abstract][Full Text] [Related]  

  • 98. Exploration of 1-(indolin-1-yl)-2-(thiazol-2-yl)ethan-1-one derivatives as novel anti-HBV agent with potential TLR7-agonistic effect.
    Li S; Yang L; Xu Q; Li X; Zhao J; Tan Z; Gu X; Qiu J
    Eur J Med Chem; 2024 Sep; 275():116575. PubMed ID: 38865744
    [TBL] [Abstract][Full Text] [Related]  

  • 99. Discovery of carboxyl-containing heteroaryldihydropyrimidine derivatives as novel HBV capsid assembly modulators with significantly improved metabolic stability.
    Zhao S; Wang Y; Zhang X; Qiao L; Wang S; Jin Y; Wu S; Li Y; Zhan P; Liu X
    RSC Med Chem; 2023 Nov; 14(11):2380-2400. PubMed ID: 37974964
    [TBL] [Abstract][Full Text] [Related]  

  • 100. Identification of (6S)-cyclopropyl-6,7-dihydropyrazolo[1,5-a]pyrazine-5(4H)-carboxamines as new HBV capsid assembly modulators.
    Lv K; Wu S; Tao Z; Wang A; Xu S; Yang L; Gao Q; Wang A; Qin X; Jiang B; Wu W; Jia X; Li Y; Jiang J; Liu M
    Eur J Med Chem; 2022 Jan; 228():113974. PubMed ID: 34772528
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.